Pipeline Reporting

Proactive Pipeline Assessment

  • Pre-Launch Impact Analysis
    • Assessment of current patient base and the likely impact of new therapies to the health plan.

Pre-Launch Clinical Criteria Development

  • Ensure readiness for the launch of new therapies.
    • Monitor clinical trials and advise the health plan related to potential place in therapy for new products.
    • Monitor pipeline to identify opportunities for preferred drug strategies based on the likely place in therapy of a new product.
    • Work with health plan to develop clinical criteria prior to launch.

Pre-Launch Step-Therapy Analysis

  • Assist in developing strategies to utilize lower cost alternatives prior to biologic or specialty therapies.
    • Generics
    • Biosimilar (Future)
    • Traditional therapy prior to biologic/specialty.